How to Use NA-931
Complete guide to NA-931 dosing, administration, timing, and protocol recommendations.
Quick Overview
NA-931 (Bioglutide) is cyclic glycine-proline, a two-amino-acid ring that occurs naturally as a breakdown product of IGF-1. Its developer, Biomed Industries, describes it as an oral once-daily agonist at four receptors at once - IGF-1, GLP-1, GIP and glucagon - and has reported 13 to 15 percent weight loss in a 126-person Phase 2 trial. Those numbers have only ever appeared in conference abstracts, never in a peer-reviewed paper, and no trial results have been filed to ClinicalTrials.gov. The same molecule is already sold as a consumer brain-health supplement and as a Sigma-Aldrich catalogue chemical, which makes it unusually cheap to source and unusually hard to verify.
Dosing Guidelines
Common Dose
120 mg daily, oral
Frequency
Once daily
Dose Range
60-150 mg daily
Note: Oral, not injectable. The molecule is 154 daltons, far too small for injection to make sense, and any vendor selling it as a reconstitute-and-inject vial is selling the wrong format. The same compound is sold as a consumer supplement.
Administration Method
Oral capsule or tablet, once daily
Best Time to Take
Consistent daily timing
Trials used once-daily oral dosing
Protocol Duration
28 days in Phase 1, 13 weeks in Phase 2
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Not FDA approved for any indication
- •No peer-reviewed safety data exists
- •Company reports diarrhea in 2.3 percent versus 10 percent on placebo, from a conference abstract only
- •Cyclic glycine-proline occurs naturally in the body and is sold as a supplement, so acute toxicity is unlikely
- •The four-receptor mechanism that would drive weight loss has never been independently confirmed
Frequently Asked Questions
What is the recommended dose for NA-931?
120 mg daily, oral
How do you administer NA-931?
Oral capsule or tablet, once daily
When is the best time to take NA-931?
Consistent daily timing
How long should you use NA-931?
28 days in Phase 1, 13 weeks in Phase 2
This information is for educational purposes only. Always consult with a healthcare professional before using any peptide. Dosing information is based on research literature and community reports, not medical advice.